Influence of environmental factors on disease activity in spondyloarthritis: A prospective cohort study

Journal of Rheumatology

Volumn 40, Issue 4, 2013, Pages 469-475

  Zeboulon Ktorza, Nadine ^a,b,c   Boelle, Pierre Yves ^c,d,e   Said Nahal, Roula ^a   D'Agostino, Maria Antonietta ^a,b   Vibert, Jean François ^c,d,e   Turbelin, Clént ^c,d   Madrakian, Homa ^a   Durand, Emmanuelle ^a   Launay, Odile ^f,g   Mahr, Alfred ^f   Flahault, Antoine ^h   Breban, Maxime ^a,b,c   Hanslik, Thomas ^a,b,c  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e HÔPITAL SAINT ANTOINE   (France)

^f université Paris Cité   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h EHESP SCHOOL OF PUBLIC HEALTH   (France)

Author keywords

Environment; Epidemiology; Life change events; Spondyloarthritis

Indexed keywords

ADULT; ANIMAL HUSBANDRY; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; BATH ANKYLOSING SPONDYLITIS FUNCTIONAL INDEX; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DUST EXPOSURE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ENVIRONMENTAL IMPACT; FEMALE; HUMAN; INFECTION; LIFE EVENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SOLVENT EXPOSURE; SPONDYLITIS; STRESS;

ADULT; DIAGNOSTIC SELF EVALUATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; LIFE CHANGE EVENTS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SPONDYLARTHRITIS; STRESS, PSYCHOLOGICAL;

EID: 84875855029     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121081     Document Type: Article

References (44)

1. Breban M, Miceli-Richard C, Zinovieva E, Monnet D, Said-Nahal R. The genetics of spondyloarthropathies. Joint Bone Spine 2006;73:355-62.
2. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: The development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
3. Claudepierre P, Sibilia J, Goupille P, Flipo RM, Wendling D, Eulry F, et al. Evaluation of a French version of the Bath Ankylosing Spondylitis Disease Activity Index in patients with spondyloarthropathy. J Rheumatol 1997;24:1954-8.
4. Claudepierre P, Sibilia J, Roudot-Thoraval F, Flipo RM, Wendling D, Goupille P, et al. Factors linked to disease activity in a French cohort of patients with spondyloarthropathy. J Rheumatol 1998;25:1927-31.
5. Rihl M, Klos A, Kohler L, Kuipers JG. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol 2006;20:1119-37.
6. Martinez A, Pacheco-Tena C, Vazquez-Mellado J, Burgos-Vargas R. Relationship between disease activity and infection in patients with spondyloarthropathies. Ann Rheum Dis 2004;63:1338-40.
7. Averns HL, Oxtoby J, Taylor HG, Jones PW, Dziedzic K, Dawes PT. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996;25:138-42.
8. Costenbader K, Laden F. What do pesticides, farming, and dose effects have to do with the risk of developing connective tissue disease? Arthritis Care Res 2011;63:175-7.
9. Zochling J, Bohl-Buhler MH, Baraliakos X, Feldtkeller E, Braun J. The high prevalence of infections and allergic symptoms in patients with ankylosing spondylitis is associated with clinical symptoms. Clin Rheumatol 2006;25:648-58.
10. Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies]. Rev Rhum Mal Osteoartic 1990;57:85-9.
11. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 1984;27:361-8.
12. de Brouwer SJ, Kraaimaat FW, Sweep FC, Creemers MC, Radstake TR, van Laarhoven AI, et al. Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses. Arthritis Res Ther 2010;12:R89.
13. Karaiskos D, Mavragani CP, Makaroni S, Zinzaras E, Voulgarelis M, Rabavilas A, et al. Stress, coping strategies and social support in patients with primary Sjogren's syndrome prior to disease onset: a retrospective case-control study. Ann Rheum Dis 2009;68:40-6.
14. Kemeny ME, Schedlowski M. Understanding the interaction between psychosocial stress and immune-related diseases: a stepwise progression. Brain Behav Immun 2007;21:1009-18.
15. Lane SE, Watts RA, Bentham G, Innes NJ, Scott DG. Are environmental factors important in primary systemic vasculitis? A case-control study. Arthritis Rheum 2003;48:814-23.
16. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328:731.
17. Parks CG, Walitt BT, Pettinger M, Chen JC, de Roos AJ, Hunt J, et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res 2011;63:184-94.
18. Pattison E, Harrison BJ, Griffiths CE, Silman AJ, Bruce IN. Environmental risk factors for the development of psoriatic arthritis: results from a case-control study. Ann Rheum Dis 2008;67:672-6.
19. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
20. Stolt P, Yahya A, Bengtsson C, Källberg H, Rönnelid J, Lundberg I, et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis 2010;69:1072-6.
21. Wahed M, Corser M, Goodhand JR, Rampton DS. Does psychological counseling alter the natural history of inflammatory bowel disease? Inflamm Bowel Dis 2010;16:664-9.
22. Garg AX, Pope JE, Thiessen-Philbrook H, Clark WF, Ouimet J, Walkerton Health Study Investigators. Arthritis risk after acute bacterial gastroenteritis. Rheumatology 2008;47:200-4.
23. Ternhag A, Torner A, Svensson A, Ekdahl K, Giesecke J. Short- and long-term effects of bacterial gastrointestinal infections. Emerg Infect Dis 2008;14:143-8.
24. Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of Spondyloarthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 2011;70:25-31.
25. Olivieri I, Gherardi S, Bini C, Trippi D, Ciompi ML, Pasero G. Trauma and seronegative spondyloarthropathy: Rapid joint destruction in peripheral arthritis triggered by physical injury. Ann Rheum Dis 1988;47:73-6.
26. Zochling J, Bohl-Buhler MH, Baraliakos X, Feldtkeller E, Braun J. Infection and work stress are potential triggers of ankylosing spondylitis. Clin Rheumatol 2006;25:660-6.
27. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity - 'Vaccinosis': A dangerous liaison? J Autoimmun 2000;14:1-10.
28. Braun J, Davis J, Dougados M, Sieper J, van der Linden S, van der Heijde D, et al. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2006;65:316-20.
29. Braun J, Pham T, Sieper J, Davis J, van der Linden S, Dougados M, et al. International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003;62:817-24.
30. Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, et al. Recommendations of the French Society for Rheumatology regarding TNF-αantagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update. Joint Bone Spine 2007;74:638-46.
31. Spoorenberg A, van Tubergen A, LandewéR, Dougados M, van der Linden S, Mielants H, et al. Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives. Rheumatology 2005;44:789-95.
32. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing Spondylitis Assessment Group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1876-86.
33. Pavy S, Brophy S, Calin A. Establishment of the minimum clinically important difference for the Bath Ankylosing Spondylitis Indices: a prospective study. J Rheumatol 2005;32:80-5.
34. Stopponi MA, Alexander GL, McClure JB, Carroll NM, Divine GW, Calvi JH, et al. Recruitment to a randomized web-based nutritional intervention trial: characteristics of participants compared to non-participants. J Med Internet Res 2009;11:e38.
35. van Uden-Kraan CF, Drossaert CH, Taal E, Seydel ER, van de Laar MA. Participation in online patient support groups endorses patients' empowerment. Patient Educ Couns 2009;74:61-9.
36. Haglund E, Bremander AB, Petersson IF, Strömbeck B, Bergman S, Jacobsson LT, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 2011;70:943-8.
37. Baysal O, Durmus B, Ersoy Y, Altay Z, Senel K, Nas K, et al. Relationship between psychological status and disease activity and quality of life in ankylosing spondylitis. Rheumatol Int 2011;31:795-800.
38. Brionez TF, Assassi S, Reveille JD, Green C, Learch T, Diekman L, et al. Psychological correlates of self-reported disease activity in ankylosing spondylitis. J Rheumatol 2010;37:829-34.
39. Martindale J, Smith J, Sutton CJ, Grennan D, Goodacre L, Goodacre JA. Disease and psychological status in ankylosing spondylitis. Rheumatology 2006;45:1288-93.
40. Ortancil O, Konuk N, May H, Sanli A, Ozturk D, Ankarali H. Psychological status and patient-assessed health instruments in ankylosing spondylitis. J Clin Rheumatol 2010;16:313-6.
41. Goodacre JA, Mander M, Dick WC. Patients with ankylosing spondylitis show individual patterns of variation in disease activity. Br J Rheumatol 1991;30:336-8.
42. Wallace DJ. Does stress or trauma cause or aggravate rheumatic disease? Baillieres Clin Rheumatol 1994;8:149-59.
43. Irwin MR. Human psychoneuroimmunology: 20 years of discovery. Brain Behav Immun 2008;22:129-39.
44. Irwin MR. Inflammation at the intersection of behavior and somatic symptoms. Psychiatr Clin North Am 2011;34:605-20.